Venture Capital

An independent candidate proposes a $50,000 graduate dividend, funded by redirecting billions in offshore pension wealth to tackle youth disenfranchisement.

A novel implant activating the body's own pathways could offer a safer, more effective alternative to traditional hormone therapies for breast cancer.

Riding a wave of strong earnings, Synaptics executives will outline their vision for AI at the Edge at key investor conferences in the coming weeks.

Kurv's new KCOP ETF offers investors a unique way to play the copper market, combining mining exposure with an options strategy for enhanced income.

Unified Women's Healthcare is launching a nationwide initiative combining telehealth and in-person visits to address a massive, underserved menopause market.

Klothea Bio's trial for a 'longevity protein' drug in Honduras pushes the boundaries of science, but raises questions about offshore research and equity.

A new partnership brings continuous health monitoring to premium care, signaling a major shift toward data-driven, value-based personalized medicine.

With a $10M seed round led by ICONIQ, Grotto AI is betting against automation, using AI to prove a human touch is the key to solving real estate's vacancy crisis.

For the tenth straight year, Sprout Social has won G2's Best Software award. See how its AI pivot and deep customer loyalty are redefining social intelligence.

A new pilot uses molecular tags and a digital ledger to track minerals from Australia to the US, aiming to end supply chain ambiguity and boost security.

Italian innovator Felicia expands with a nationwide Amazon launch, award-winning oat penne, and a new strategy to redefine the better-for-you pasta market.

The Swedish tech firm will debut its AI Checklist Builder and Safety Alerts at CONEXPO 2026, aiming to transform high-risk industrial operations.

As it heads to key conferences, Orchestra BioMed is pitching its novel pacemaker-based hypertension treatment and a unique drug-eluting balloon.

MTP Intelligence aims to shatter data silos, integrating creative, media, and commerce with AI to deliver unprecedented clarity and accountability for brands.

Clene Inc. faces investors with promising data for ALS and MS, but a looming cash crunch makes its upcoming conference a critical test of survival.

An international team receives a major grant to use artificial intelligence to predict survival and treatment response, offering new hope for a deadly disease.

Princeton NuEnergy hires a battery industry titan to spearhead its commercial push, aiming to dominate the booming U.S. battery recycling market.

Reunion Neuroscience hits the investor conference circuit, seeking capital to advance its groundbreaking psychedelic-inspired therapies for depression and anxiety.

With two strategic hires from TriNetX and Canon Medical, Avandra signals an aggressive push to unlock siloed medical imaging data for research and AI.

Five Alberta First Nations launch a legal challenge against a federal-provincial deal, citing a lack of consent for the world's largest proposed CCS project.